Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Curios Welcomes Kevin J. Anderson and WordFire Press to Their Book Marketplace
-
Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer
-
U.S. Veterans Magazine Honors The Queen Mary's 90th Anniversary with Service to Our Country Award for Supporting U.S. Troops and Veterans
-
Loblaw Partners with Canadian AI Company Shakudo to Accelerate Its AI Adoption and Deployment
-
GHD identifies the forces that will define Miami by 2050
-
Prospect Capital Completes $26 Million Investment in Security Fire Systems
-
Max Power Appoints Tony Van Burgsteden as CFO to Support Commercial Advancement of Saskatchewan’s First Subsurface Natural Hydrogen System
-
High operating costs and uneven consumer spending put Canada’s restaurant sector – a key economic engine – under pressure
-
Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
-
Indivior Announces $175 Million Accelerated Share Repurchase
-
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
-
GFG Significantly Expands Goldarm Property Following Encouraging Regional Exploration Results in the Timmins Gold District
-
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
-
COREWELL HEALTH EAST TEAMSTERS TO PRACTICE PICKET AT FARMINGTON HILLS CAMPUS
-
Introducing Vylor: Corteva Spinoff to Propel Agriculture Further
-
NAPCO Security Technologies, Inc. Reports Fiscal 2026 Q3 Results
-
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
-
Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease
-
Ascidian Completes Dose Escalation Portion of Phase 1/2 STELLAR Trial of ACDN-01 for Stargardt Disease and Announces Expanded Clinical Study Plans
-
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
-
RADCOM to Report First Quarter 2026 Results on Tuesday, May 19, 2026
-
ZOA® Energy Enters Its Next Chapter with Real, Everyday Energy with New Campaign, Packaging Refresh and Seasonal Flavor Launch
-
ROIS establishes itself as Global CDMO with US Expansion
-
Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network
-
Back for Good! Popeyes® Makes Fan-Favorite Chicken Wraps a Permanent Menu Offering and Debuts NEW Blackened Ranch Flavor
-
Nuclear Vision Limited Announces Name Change to Union Power Metals Corporation Effective May 4, 2026 and Launch of New Corporate Website
-
GRIN Therapeutics' Pivotal Phase 3 Beeline Study Initiated in Europe
-
Green Thumb Industries Files Applications for DEA Registration Following Historic Rescheduling of Medical Cannabis
-
10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails
-
Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026
-
Legence Sets First Quarter 2026 Earnings Release Date and Webcast Schedule
-
Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site
-
Blaize and Winmate Sign Strategic Partnership Agreement to Bring AI to Rugged Systems for Defense and Critical Infrastructure
-
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
-
Modine to Participate in Upcoming Oppenheimer Virtual Conference on May 5, 2026
-
Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design
-
A2Z Cust2Mate Solutions to Host First Quarter 2026 Financial Results Conference Call on Friday, May 15, 2026
-
NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI
-
Praecipio Bets on AI at Every Level, with new AI-Enabled Cloud Solutions, Expert Teams, and An Org-Wide Commitment to Building AI Expertise
-
CW Petroleum Corp (OTCQB: CWPE) Reports Year-End 2025
-
AVISTA HEALTHCARE PARTNERS LAUNCHES BIRCHWELL CONSUMER HEALTH AS NEW OVER-THE-COUNTER PLATFORM; ACQUIRES BAG BALM AS FIRST INVESTMENT
-
Weight-Loss Drugs' Gains Lift Pharma R&D Returns, but 'Bubble' Risk Grows
-
OTC Markets Group Welcomes FORTE MINERALS CORP. to OTCQX
-
Elysian Softech Announces Mastermind - A Platform For Developing AI Agents Using Simple Prompts
-
Pecoy Copper Commences Third Drill Rig as Exploration Momentum Builds
-
Forgent Power Solutions, Inc. to Report Fiscal Third Quarter 2026 Results
-
Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
-
New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett's Esophagus
-
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
-
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits
